Nexien BioPharma, Inc. (NXEN)
USD 0.01
(7.14%)
USD 0.01
(7.14%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 155.66 Thousand | 282.6 Thousand | 563.99 Thousand | 1.84 Million | 2.63 Million | 3.93 Million |
| Selling, General and Administrative Expenses | 155.66 Thousand | 282.6 Thousand | 563.99 Thousand | 1.84 Million | 2.63 Million | 3.86 Million |
| Research and Development Expenses | - | - | - | - | - | 63.85 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 155.66 Thousand | 282.6 Thousand | 563.99 Thousand | 1.84 Million | 2.63 Million | 3.93 Million |
| Operating Income | -155.66 Thousand | -282.6 Thousand | -563.99 Thousand | -1.84 Million | -2.63 Million | -3.56 Million |
| Interest Expense | 83.45 Thousand | 79.29 Thousand | 62.36 Thousand | 16.17 Thousand | 33.00 | - |
| Income Tax Expense | -239.11 Thousand | -282.61 | -563.99 | 16.17 Thousand | 33.00 | 735.83 Thousand |
| Earnings before Tax | -239.11 Thousand | -361.9 Thousand | -626.35 Thousand | -1.85 Million | -2.67 Million | -4.3 Million |
| Net Income | -239.11 Thousand | -361.9 Thousand | -626.35 Thousand | -1.87 Million | -2.67 Million | -5.03 Million |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.01 | -0.03 | -0.05 | -0.10 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.01 | -0.03 | -0.05 | -0.10 |
| Weighted Average Shares Outstanding | 66.19 Million | 62.33 Million | 57.86 Million | 55.39 Million | 53.91 Million | 51.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 66.19 Million | 62.33 Million | 57.86 Million | 55.39 Million | 53.91 Million | 51.03 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -155.66 Thousand | -282.6 Thousand | - | -1.84 Million | - | -367.91 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 64.28 Thousand | 15.94 Thousand | 13.43 Thousand | 61.99 Thousand | 282.6 Thousand | 65.88 Thousand |
| Selling, General and Administrative Expenses | 64.28 Thousand | 15.94 Thousand | 13.43 Thousand | 61.99 Thousand | - | 65.88 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 64.28 Thousand | 15.94 Thousand | 13.43 Thousand | 61.99 Thousand | 282.6 Thousand | 65.88 Thousand |
| Operating Income | -64.28 Thousand | -15.94 Thousand | -13.43 Thousand | -61.99 Thousand | -282.6 Thousand | -65.88 Thousand |
| Interest Expense | 22.22 Thousand | 37.21 Thousand | 11.08 Thousand | 12.92 Thousand | 79.29 Thousand | 27.69 Thousand |
| Income Tax Expense | 1.00 | -15.94 Thousand | -13.44 | -61.99 | -282.61 | -65.89 |
| Earnings before Tax | -86.51 Thousand | -53.16 Thousand | -24.51 Thousand | -74.91 Thousand | -361.9 Thousand | -93.58 Thousand |
| Net Income | -86.51 Thousand | -53.16 Thousand | -24.51 Thousand | -74.91 Thousand | -361.9 Thousand | -93.58 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 64.02 Million | 66.38 Million | 65.1 Million | 64.57 Million | 62.33 Million | 64.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.02 Million | 66.38 Million | 65.1 Million | 64.57 Million | 62.33 Million | 64.02 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -64.28 Thousand | -15.94 Thousand | -13.43 Thousand | -61.99 Thousand | - | -65.88 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
5918
BRKWF
TRMLF
JEXYY
PATELSAI
0HD0